Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer

Participants will self-administer 500mg metformin twice daily by mouth: 1) beginning 1-2 weeks prior to standard of care CRT, 2) during standard of care CRT and 3) until 30 days after the end of standard of care CRT.